https://patents.google.com/patent/US6245531B1/

  • Q: is there “morgellons” in the face masks?

a relevant part of the patent text:

 

The invention was originally about trying to develop more specifically targeted pesticides that won’t have side effects on humans or other organisms. So, the question is now: is there “morgellons” in the face masks and are they targeting humans? 

Is the intent to reprogram humans or is it part of a depopulation program?

Telegrammed message – copy paste:

Morgellons Patent – US6245531 – Polynucleotide Encoding Insect Ecdysone Receptor
https://www.instagram.com/p/CNbS_-TAqyg/

Interestingly enough, the CDC spent 4 years and $600,000 using the worlds largest database trying to identify the source of the fibers found on Morgellons patients, only to conclude that they were merely delusional. Maybe the following explains why the disease is considered controversial, why the CDC dismissed it as delusions, and why the patent for methods to treat Morgellons was abandoned.

Due to the following US patent it is believed that Morgellons is not a disease, but rather a militarized fingerprintless bioweapon capable of altering DNA/RNA. The patent abstract states “Polynucleotide Sequences which encode ecdysone receptors have been isolated and expressed in host cells.” Polynucleotides are DNA & RNA (a combination of biopolymers made of 13 or more nucleotide monomers in a chain). This is a form of forced evolution of the human genome where DNA/RNA is being used to change or replace genes in animal and plant cells. In summary, this synthetic insect gene therapy believed to be Morgellons is the fetal stage of transhumanism being cast upon us with the use of the daily chemtrail operations, GMO food, and now even face masks.

“Face Mask Dangers: Hypoxia, Immunodeficiency & Morgellons Lead To The Causation of COVID-19 Symptoms”
https://www.humorousmathematics.com/post/face-mask-dangers-hypoxia-reduced-immune-efficiency-causation-of-covid-19-symptoms

 

Polynucleotides are indeed DNA and RNA, but in the sense of this patent US6245531B1 they are simply genes that express the ecdysone receptor protein.

However; I urge these people to focus in on this patent as it may be more relevant:
https://patents.google.com/patent/EP1112360A1

 

Normally, humans don’t have a receptor for ecdysone, so it can be used as a targeted “switch”. The idea is that you introduce the genetic coding for an ecdysone receptor into the cells, along with the genetic coding to create some other protein which will have therapeutic effects.

When you then introduce ecdysone (or a similar steroid that can bind to an ecdysone receptor), it will act as a switch to turn on production of the other protein.

This is a link to a commercial application of the technology: http://www.genomics.agilent.com/article.jsp?pageId=496&_requestid=937758

So, in summary:

Yes, ecdysone receptors are being used in gene therapy. But this is just one method of turning on the gene expression, and ecdysone by itself just acts as the switch to cause “a gene” to be turned on. Nowhere in any of this is there any evidence for the supposed artificial gene that is being switched on to cause or create morgellons! Nor can these patents be said to be morgellons. 

However I would study whether these patents/tech is used in conjunction with:
https://www.graphene-info.com/graphene-introduction

https://news.mit.edu/2012/injectable-gels-staying-solid-1116

 

This may also be worth studying:
This web page summarizes information in PubChem about patent US-7563928-B2:

https://pubchem.ncbi.nlm.nih.gov/patent/US7563928